Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Which medication is the primary treatment for muscarinic effects in acute organophosphate poisoning?

Atropine. ***Atropine*** - **Atropine** is a **muscarinic receptor antagonist** that directly blocks the effects of excessive acetylcholine at muscarinic sites, thereby reversing symptoms like bradycardia, bronchospasm, and excessive secretions seen in organophosphate poisoning. - It is the **primary agent** used to manage the muscarinic symptoms and is titrated until bronchorrhea and bronchospasm resolve. *Neostigmine* - **Neostigmine** is an **acetylcholinesterase inhibitor**, which would worsen the condition by increasing acetylcholine levels further. - It is used in conditions like **myasthenia gravis** to improve muscle strength, not in organophosphate poisoning. *Tubocurarine* - **Tubocurarine** is a **nicotinic receptor antagonist**, specifically a competitive neuromuscular blocker. - While organophosphate poisoning can affect nicotinic receptors, tubocurarine is not the primary treatment for muscarinic effects and could worsen respiratory depression in this context. *Pralidoxime* - **Pralidoxime** (2-PAM) is an **acetylcholinesterase reactivator** that can regenerate the enzyme, thereby reversing both muscarinic and nicotinic effects. - While crucial for reversing nicotinic effects and preventing 'aging' of the enzyme, it is **not the primary treatment for acute muscarinic crisis**; atropine is.

Q: Which of the following is not a known side effect of dantrolene?

Hypertension. Hypertension- Hypertension is not a known side effect of dantrolene; in fact, dantrolene typically causes hypotension rather than elevated blood pressure.- The drug's muscle relaxant properties and effects on calcium regulation can lead to decreased peripheral vascular resistance and cardiovascular depression.- Cardiovascular side effects of dantrolene include hypotension and bradycardia, not hypertension.Muscle weakness- Dantrolene acts by inhibiting calcium release from the sarcoplasmic reticulum, directly interfering with muscle contraction.- This mechanism of action leads to generalized muscle weakness, which is one of the most common side effects, especially at higher doses.Phlebitis- Intravenous dantrolene commonly causes local irritation and inflammation of the vein (phlebitis/thrombophlebitis).- This occurs because the IV preparation is highly alkaline (pH ~9.5) and can cause venous irritation, particularly when administered through peripheral veins.Respiratory insufficiency- Due to its muscle relaxant properties, dantrolene can affect respiratory muscles, potentially leading to respiratory depression or insufficiency.- This risk is higher in patients with pre-existing respiratory conditions or when dantrolene is used with other CNS/respiratory depressants.

Q: In which of the following conditions is morphine use LEAST contraindicated?

Ischemic heart disease patients. ***Ischemic heart disease patients*** - Morphine is often used in **acute myocardial infarction** to reduce pain and anxiety, which can decrease cardiac workload. - It causes **venodilation**, reducing preload and myocardial oxygen demand, which is beneficial in ischemia. *Bronchial asthma patients* - Morphine can induce **histamine release**, which can cause bronchospasm and exacerbate asthma symptoms. - Patients with **reactive airway disease** are at higher risk for respiratory depression and adverse effects from opioids. *Elderly male patients* - Elderly men may experience increased **urinary retention** due to prostatic hypertrophy, which morphine can worsen by increasing sphincter tone. - They are also more susceptible to morphine's side effects like **respiratory depression** and **constipation** due to altered metabolism and excretion. *Biliary colic patients* - Morphine can cause **spasm of the Sphincter of Oddi**, leading to increased pressure in the bile duct and exacerbating biliary pain. - While it relieves pain, this specific side effect makes it less ideal compared to other pain medications for biliary colic.

Q: Which electrolyte component is present in Oral Rehydration Solution (ORS) at a concentration of 75 mmol/litre?

Sodium. ***Sodium*** - The **WHO-recommended** ORS formulation contains **sodium** at a concentration of **75 mmol/L**. This concentration is crucial for optimizing water and electrolyte absorption through the **sodium-glucose co-transport mechanism** [1] in the small intestine. [2] - Adequate sodium replacement is vital to correct **hyponatremia** and prevent further dehydration, especially in individuals with **acute diarrheal diseases**. *Potassium* - While ORS does contain potassium, its concentration is typically **20 mmol/L**, not 75 mmol/L. This is to replenish losses and prevent **hypokalemia**, which can worsen with diarrhea. [2] - Excessive potassium could be harmful, especially in individuals with impaired renal function. *Glucose* - Glucose is present at a concentration of **75 mmol/L**, but it is a sugar, not an electrolyte. It's essential for co-transporting sodium and water into enterocytes. [1] - While crucial for ORS efficacy, glucose itself directly contributes to osmolality and absorption, but is not an electrolyte. *Chloride* - Chloride is also present in ORS for maintaining **electroneutrality** and is absorbed along with sodium. [2] - The typical concentration of chloride in WHO ORS is **65 mmol/L**, not 75 mmol/L.

Q: Cisapride was withdrawn from the market due to?

QT Prolongation. ***QT Prolongation*** - Cisapride was withdrawn from the market primarily due to its association with **dose-dependent QT interval prolongation**, which increased the risk of serious ventricular arrhythmias. - This **QT prolongation** could lead to potentially fatal **Torsades de Pointes**, a polymorphic ventricular tachycardia. *PR interval prolongation* - While some medications can affect the PR interval, **cisapride's primary cardiac concern** was specifically related to the QT interval, not the PR interval. - PR interval changes generally indicate issues with **AV nodal conduction**, a different mechanism than that affected by cisapride. *Hepatotoxicity* - Although drug-induced liver injury is a known adverse effect for many medications, **hepatotoxicity was not the primary reason** for cisapride's withdrawal. - The most significant and life-threatening adverse effect was its impact on cardiac repolarization. *Nephrotoxicity* - **Nephrotoxicity (kidney damage)** was not identified as a major or significant adverse effect associated with cisapride that led to its market withdrawal. - The drug's safety profile concerns were focused on its cardiovascular effects.

Question 1

Which medication is the primary treatment for muscarinic effects in acute organophosphate poisoning?

Accepted Answer

Atropine

Answer

Tubocurarine

Answer

Neostigmine

Answer

Pralidoxime

Question 2

Which of the following is not a known side effect of dantrolene?

Accepted Answer

Hypertension

Answer

Muscle weakness

Answer

Phlebitis

Answer

Respiratory insufficiency

Question 3

In which of the following conditions is morphine use LEAST contraindicated?

Accepted Answer

Ischemic heart disease patients

Answer

Bronchial asthma patients

Answer

Elderly male patients

Answer

Biliary colic patients

Question 4

Which electrolyte component is present in Oral Rehydration Solution (ORS) at a concentration of 75 mmol/litre?

Accepted Answer

Sodium

Answer

Potassium

Answer

Glucose

Answer

Chloride

Question 5

Cisapride was withdrawn from the market due to?

Accepted Answer

QT Prolongation

Answer

Hepatotoxicity

Answer

Nephrotoxicity

Answer

PR interval prolongation

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?